CDKN2A and angiosarcoma: We successfully generated new models of angiosarcoma and of UPS based on oncogenic HrasG12V expression in combination with knockdown of Cdkn2a or Trp53. Unexpectedly, different mouse strains developed different types of sarcoma in response to identical genetic drivers.